Literature DB >> 20410726

Cognitive and psychiatric predictors to psychosis in velocardiofacial syndrome: a 3-year follow-up study.

Kevin M Antshel1, Robert Shprintzen, Wanda Fremont, Anne Marie Higgins, Stephen V Faraone, Wendy R Kates.   

Abstract

OBJECTIVE: To predict prodromal psychosis in adolescents with velocardiofacial syndrome (VCFS).
METHOD: A total of 70 youth with VCFS, 27 siblings of youth with VCFS, and 25 community controls were followed from childhood (mean age = 11.8 years) into mid-adolescence (mean age = 15.0 years). Psychological tests measuring intelligence, academic achievement, learning/memory, attention, and executive functioning as well as measures of parent and clinician ratings of child psychiatric functioning were completed at both time points.
RESULTS: Major depressive disorder, oppositional defiant disorder, and generalized anxiety disorder diagnoses increased in the VCFS sample. With very low false positive rates, the best predictor of adolescent prodromal psychotic symptoms was parent ratings of childhood odd/eccentric symptoms and child performance on a measure of executive functioning, the Wisconsin Card Sorting Test.
CONCLUSIONS: Similar to the non-VCFS prodromal psychosis literature, a combination of cognitive and psychiatric variables appears to predict psychosis in adolescence. A child with VCFS who screens positive is noteworthy and demands clinical attention.

Entities:  

Mesh:

Year:  2010        PMID: 20410726      PMCID: PMC2918883     

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN: 0890-8567            Impact factor:   8.829


  84 in total

Review 1.  D(1) receptors in prefrontal cells and circuits.

Authors:  P S Goldman-Rakic; E C Muly; G V Williams
Journal:  Brain Res Brain Res Rev       Date:  2000-03

Review 2.  Research on behavioral phenotypes: velocardiofacial syndrome (deletion 22q11.2).

Authors:  P P Wang; M F Woodin; R Kreps-Falk; E M Moss
Journal:  Dev Med Child Neurol       Date:  2000-06       Impact factor: 5.449

3.  Velocardiofacial syndrome in childhood-onset schizophrenia.

Authors:  S I Usiskin; R Nicolson; D M Krasnewich; W Yan; M Lenane; M Wudarsky; S D Hamburger; J L Rapoport
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1999-12       Impact factor: 8.829

Review 4.  Schizophrenia and velo-cardio-facial syndrome.

Authors:  Kieran C Murphy
Journal:  Lancet       Date:  2002-02-02       Impact factor: 79.321

Review 5.  Velo-cardio-facial syndrome: a model for understanding the genetics and pathogenesis of schizophrenia.

Authors:  K C Murphy; M J Owen
Journal:  Br J Psychiatry       Date:  2001-11       Impact factor: 9.319

6.  Diagnosis and treatment of psychiatric disorders in children with a schizophrenic parent.

Authors:  R G Ross; N Compagnon
Journal:  Schizophr Res       Date:  2001-05-30       Impact factor: 4.939

7.  The neurocognitive phenotype of the 22q11.2 deletion syndrome: selective deficit in visual-spatial memory.

Authors:  C E Bearden; M F Woodin; P P Wang; E Moss; D McDonald-McGinn; E Zackai; B Emannuel; T D Cannon
Journal:  J Clin Exp Neuropsychol       Date:  2001-08       Impact factor: 2.475

8.  Neuropsychological, learning and psychosocial profile of primary school aged children with the velo-cardio-facial syndrome (22q11 deletion): evidence for a nonverbal learning disability?

Authors:  A Swillen; L Vandeputte; J Cracco; B Maes; P Ghesquière; K Devriendt; J P Fryns
Journal:  Child Neuropsychol       Date:  1999-12       Impact factor: 2.500

9.  Psychiatric disorders and behavioral problems in children with velocardiofacial syndrome: usefulness as phenotypic indicators of schizophrenia risk.

Authors:  Carl Feinstein; Stephan Eliez; Christine Blasey; Allan L Reiss
Journal:  Biol Psychiatry       Date:  2002-02-15       Impact factor: 13.382

10.  Neuropsychological profile of children and adolescents with the 22q11.2 microdeletion.

Authors:  M Woodin; P P Wang; D Aleman; D McDonald-McGinn; E Zackai; E Moss
Journal:  Genet Med       Date:  2001 Jan-Feb       Impact factor: 8.822

View more
  56 in total

1.  Caregiver and adult patient perspectives on the importance of a diagnosis of 22q11.2 deletion syndrome.

Authors:  G Costain; E W C Chow; P N Ray; A S Bassett
Journal:  J Intellect Disabil Res       Date:  2011-12-06

Review 2.  Behavioral and Psychiatric Phenotypes in 22q11.2 Deletion Syndrome.

Authors:  Kerri L Tang; Kevin M Antshel; Wanda P Fremont; Wendy R Kates
Journal:  J Dev Behav Pediatr       Date:  2015-10       Impact factor: 2.225

Review 3.  Genetics in child and adolescent psychiatry: methodological advances and conceptual issues.

Authors:  Sarah Hohmann; Nicoletta Adamo; Benjamin B Lahey; Stephen V Faraone; Tobias Banaschewski
Journal:  Eur Child Adolesc Psychiatry       Date:  2015-04-08       Impact factor: 4.785

4.  Working Memory Impairments in Chromosome 22q11.2 Deletion Syndrome: The Roles of Anxiety and Stress Physiology.

Authors:  Ashley F P Sanders; Diana A Hobbs; David D Stephenson; Robert D Laird; Elliott A Beaton
Journal:  J Autism Dev Disord       Date:  2017-04

Review 5.  The 22q11.2 deletion syndrome as a window into complex neuropsychiatric disorders over the lifespan.

Authors:  Rachel K Jonas; Caroline A Montojo; Carrie E Bearden
Journal:  Biol Psychiatry       Date:  2013-08-28       Impact factor: 13.382

6.  Biological effects of COMT haplotypes and psychosis risk in 22q11.2 deletion syndrome.

Authors:  Doron Gothelf; Amanda J Law; Amos Frisch; Jingshan Chen; Omer Zarchi; Elena Michaelovsky; Renee Ren-Patterson; Barbara K Lipska; Miri Carmel; Bhaskar Kolachana; Abraham Weizman; Daniel R Weinberger
Journal:  Biol Psychiatry       Date:  2013-08-28       Impact factor: 13.382

7.  Subthreshold psychotic symptoms in 22q11.2 deletion syndrome.

Authors:  Sunny X Tang; James J Yi; Tyler M Moore; Monica E Calkins; Christian G Kohler; Daneen A Whinna; Margaret C Souders; Elaine H Zackai; Donna M McDonald-McGinn; Beverly S Emanuel; Warren B Bilker; Ruben C Gur; Raquel E Gur
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2014-06-19       Impact factor: 8.829

8.  Psychiatric disorders in 22q11.2 deletion syndrome are prevalent but undertreated.

Authors:  S X Tang; J J Yi; M E Calkins; D A Whinna; C G Kohler; M C Souders; D M McDonald-McGinn; E H Zackai; B S Emanuel; R C Gur; R E Gur
Journal:  Psychol Med       Date:  2013-09-09       Impact factor: 7.723

Review 9.  Converging levels of analysis on a genomic hotspot for psychosis: insights from 22q11.2 deletion syndrome.

Authors:  Matthew J Schreiner; Maria T Lazaro; Maria Jalbrzikowski; Carrie E Bearden
Journal:  Neuropharmacology       Date:  2012-10-23       Impact factor: 5.250

10.  Examining the durability of a hybrid, remote and computer-based cognitive remediation intervention for adolescents with 22q11.2 deletion syndrome.

Authors:  Margaret A Mariano; Kerri Tang; Matthew Kurtz; Wendy R Kates
Journal:  Early Interv Psychiatry       Date:  2016-09-15       Impact factor: 2.732

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.